Dixon Mitchell Investment Counsel Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,013 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
Dixon Mitchell Investment Counsel Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$1,703
-100.0%
16
-100.0%
0.00%
-100.0%
Q2 2021$9,416,607
+6.6%
103,207
-0.1%
0.70%
-4.4%
Q1 2021$8,831,281
+2.7%
103,314
+13.5%
0.73%
-1.6%
Q4 2020$8,595,585
+8.4%
91,026
-0.1%
0.74%
-4.6%
Q3 2020$7,927,100
+81.7%
91,158
+82.5%
0.78%
+62.3%
Q2 2020$4,363,332
+11.5%
49,958
+5.3%
0.48%
-2.6%
Q1 2020$3,912,088
-19.9%
47,448
-8.0%
0.49%
-4.8%
Q4 2019$4,882,311
+11.2%
51,561
+2.1%
0.52%
+3.6%
Q3 2019$4,388,798
-5.5%
50,504
-0.7%
0.50%
-4.8%
Q2 2019$4,644,848
-2.7%
50,869
+2.4%
0.52%
-7.1%
Q1 2019$4,774,120
-44.7%
49,658
-50.7%
0.56%
-51.1%
Q4 2018$8,634,631
-1.7%
100,625
-1.3%
1.16%
+12.9%
Q3 2018$8,787,200
+14.9%
101,987
+0.7%
1.02%
+5.9%
Q2 2018$7,647,745
-5.2%
101,241
+1.5%
0.97%
-9.3%
Q1 2018$8,065,758
+0.0%
99,762
+3.9%
1.07%
+3.3%
Q4 2017$8,064,358
+5.2%
96,050
+7.5%
1.03%
+0.9%
Q3 2017$7,669,066
+2.2%
89,331
-0.6%
1.02%
-3.4%
Q2 2017$7,502,617
+14.0%
89,884
+1.4%
1.06%
+11.1%
Q1 2017$6,581,733
+23.2%
88,619
+20.8%
0.95%
+18.2%
Q4 2016$5,344,052
-2.7%
73,367
+5.4%
0.81%
-5.7%
Q3 2016$5,494,590
+2.7%
69,587
+7.3%
0.86%
-3.6%
Q2 2016$5,351,764
+18.1%
64,862
+3.7%
0.89%
+20.7%
Q1 2016$4,530,760
-14.6%
62,545
+1.4%
0.74%
-18.5%
Q4 2015$5,308,152
-1.1%
61,694
+5.6%
0.90%
-3.0%
Q3 2015$5,367,852
-4.3%
58,397
+2.3%
0.93%
+7.4%
Q2 2015$5,611,870
+1.4%
57,066
+1.6%
0.87%
+1.6%
Q1 2015$5,536,853
+67.1%
56,149
+59.5%
0.85%
+66.4%
Q4 2014$3,314,2230.0%35,2090.0%0.51%
+2.2%
Q3 2014$3,314,223
+6.2%
35,209
+2.2%
0.50%
+12.1%
Q2 2014$3,119,392
+10.8%
34,457
+4.0%
0.45%
+0.9%
Q1 2014$2,815,692
+16.3%
33,118
+9.9%
0.44%
+15.4%
Q4 2013$2,422,091
+11.6%
30,133
+6.5%
0.38%
+4.6%
Q3 2013$2,170,279
+36.3%
28,292
+25.7%
0.37%
+24.0%
Q2 2013$1,591,824
+19.1%
22,512
+20.0%
0.30%
+20.8%
Q1 2013$1,336,819
-16.2%
18,765
-25.5%
0.24%
-24.1%
Q4 2012$1,594,844
+5.9%
25,195
+2.5%
0.32%
-2.1%
Q3 2012$1,505,465
+16.8%
24,575
+6.6%
0.33%
+7.5%
Q2 2012$1,288,495
+6.5%
23,050
+5.6%
0.31%
+7.7%
Q1 2012$1,209,600
+224.5%
21,830
+234.8%
0.28%
+190.8%
Q4 2011$372,7486,5200.10%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders